TrialGene therapy2016

Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure.

B Greenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.